Control of Cardiovascular Risk Factors in Revascularized Patients With Diabetes: A Subanalysis of the ICP-Bypass Study
Pilar Mazón‐Ramos(Universidade de Santiago de Compostela), Silvia Fernández-Anaya(MSD (Spain)), Alberto Cordero(Hospital Universitari Sant Joan D'Alacant), Vicente Bertoméu, G. Vitale(MSD (Spain)), Elías Delgado(Hospital Universitario Central de Asturias), José Ramón González‐Juanatey(Centro de Investigación en Red en Enfermedades Cardiovasculares)
Cited by 2
Related Papers
Empagliflozin in Heart Failure with a Preserved Ejection Fraction
|New England Journal of Medicine|2021|4.6k
Periodontitis and cardiovascular diseases: Consensus report
|Journal Of Clinical Periodontology|2020|1.5k
Classification, prevalence, and outcomes of anticancer therapy-induced cardiotoxicity: the CARDIOTOX registry
|European Heart Journal|2020|282
Periodontitis and Cardiovascular Diseases. Consensus Report
|Global Heart|2020|274
Patient Phenotype Profiling in Heart Failure with Preserved Ejection Fraction to Guide Therapeutic Decision Making. A Scientific Statement of the Heart Failure Association, the European Heart Rhythm Association of the European Society of Cardiology, and the European Society of Hypertension
|European Journal of Heart Failure|2023|187